Yunqi Capital at WAIC 2023: Three New Opportunities for Large Model Deployment
And, Yunqi Capital's AGI+ portfolio has added these new products —
And, Yunqi Capital's AGI+ portfolio has added these new products —
Accelerating clinical trials and R&D for ophthalmic and microsurgical robotic products.
你带上好奇心,我们一起不被定义
Mark Zuckerberg Takes On Elon Musk
Consensus can form quickly — and dissolve just as fast.
The truly valuable investment opportunities in the AI wave are the "non-tech" plays.
Xiyunda — making cross-border expansion simpler.
Closing In Step by Step
Empowerment is a big deal.
Notable developments to watch in June.